OHSU
Return to Listing

6 result(s) for Other

PI Name Protocol # Title
Jeremy Cetnar IRB00007669 An Open Label, Multi-center, IRESSA Clinical Access Program of Gefitinib 250 mg (IRESSA) for the Continued Treatment of Patients in the United States Who Are Currently Benefiting or Have Benefited from Gefitinib Treatment
Kerri Winters IRB00008560 Group Exercise Training for Functional Improvement after Treatment: The GET FIT Trial
Richard Maziarz IRB00008706 A Phase II Controlled Trial of a Single ProHema-CB unit (Ex Vivo CXCR4-Upregulated CD34+ Hematopoietic Progenitor Cells, Cord Blood) As Part of a Double Umbilical Cord Blood Transplant Following Myeloablative Conditioning For Patients Age 15-65 Years With Hematologic Malignancies
Emma Scott IRB00009421 A Phase I Dose-Escalation Study of Carfilzomib in Patients with Previously-Treated Systemic Light-Chain (AL) Amyloidosis
Lynn Jansen IRB00009697 Understanding parental (and adolescent) risk/benefit assessments in research
Paul Spellman IRB00010163 Reconstructing the Tumor Genome in Peripheral Blood
 
For more information:
Email: trials@ohsu.edu
Call: 503-494-1080
 

You may qualify for additional trials within our Phase 1 Program